Stay updated on ELAD Safety and Efficacy in AILD Clinical Trial
Sign up to get notified when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.

Latest updates to the ELAD Safety and Efficacy in AILD Clinical Trial page
- Check6 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer's displayed site revision changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing the usual content and indicating restricted access to the study details.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error. It replaces the previous study-record content with an error message and a Home link, indicating access is blocked.SummaryDifference20%

- Check62 days agoChange DetectedPage revision tag updated from v3.6.5 to v3.6.6, indicating a minor metadata update. No study content or results are changed.SummaryDifference0.0%

Stay in the know with updates to ELAD Safety and Efficacy in AILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.